Home > Qtrly Results > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Quarterly Results Analysis [Sep2025]

DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Quarterly Results

Consolidated Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹8,828 Cr ₹8,572 Cr ₹8,528 Cr ₹8,381 Cr ₹8,038 Cr ₹7,696 Cr ₹7,114 Cr ₹7,237 Cr
Expenses ₹6,818 Cr ₹6,399 Cr ₹6,531 Cr ₹6,108 Cr ₹5,962 Cr ₹5,566 Cr ₹5,283 Cr ₹5,214 Cr
Operating Income ₹2,010 Cr ₹2,174 Cr ₹1,998 Cr ₹2,273 Cr ₹2,077 Cr ₹2,130 Cr ₹1,831 Cr ₹2,023 Cr
Other Income ₹324 Cr ₹290 Cr ₹522 Cr ₹150 Cr ₹308 Cr ₹187 Cr ₹198 Cr ₹216 Cr
Interest ₹91 Cr ₹83 Cr ₹66 Cr ₹82 Cr ₹76 Cr ₹60 Cr ₹59 Cr ₹39 Cr
Depreciation ₹505 Cr ₹476 Cr ₹455 Cr ₹471 Cr ₹397 Cr ₹381 Cr ₹368 Cr ₹374 Cr
Profit Before Tax ₹1,739 Cr ₹1,905 Cr ₹2,000 Cr ₹1,870 Cr ₹1,911 Cr ₹1,877 Cr ₹1,602 Cr ₹1,826 Cr
Profit After Tax ₹1,331 Cr ₹1,410 Cr ₹1,581 Cr ₹1,400 Cr ₹1,336 Cr ₹1,387 Cr ₹1,306 Cr ₹1,378 Cr
EPS ₹16.13 ₹16.98 ₹19.10 ₹16.95 ₹75.28 ₹16.70 ₹15.71 ₹16.56
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES -6.8% -2.1% -8.4%
SUN PHARMACEUTICAL INDUSTRIES -0.3% 6% -10.5%
DIVIS LABORATORIES 3.9% 18.6% 14.5%
CIPLA -5.2% NA 2.5%
TORRENT PHARMACEUTICALS -1% -1.2% 8.7%
MANKIND PHARMA -1.4% -2.2% 0.7%
ZYDUS LIFESCIENCES -3.9% -0.7% -2%
LUPIN 2.2% 2.8% -11.8%
AUROBINDO PHARMA 4% 5.1% -23.1%

DR REDDYS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

2.99 %

Y-o-Y

9.83 %

Quarters Revenues % Change
Sep2025 ₹8,828 Cr
2.99
Jun2025 ₹8,572 Cr
0.51
Mar2025 ₹8,528 Cr
1.76
Dec2024 ₹8,381 Cr
4.27
Sep2024 ₹8,038 Cr
4.45
Jun2024 ₹7,696 Cr
8.19
Mar2024 ₹7,114 Cr
-1.70
Dec2023 ₹7,237 Cr -

DR REDDYS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-7.53 %

Y-o-Y

-3.21 %

Quarters Operating Profit % Change
Sep2025 ₹2,010 Cr
-7.53
Jun2025 ₹2,174 Cr
8.79
Mar2025 ₹1,998 Cr
-12.10
Dec2024 ₹2,273 Cr
9.46
Sep2024 ₹2,077 Cr
-2.51
Jun2024 ₹2,130 Cr
16.31
Mar2024 ₹1,831 Cr
-9.49
Dec2023 ₹2,023 Cr -
Operating Margins
Q-o-Q

-10.21 %

Y-o-Y

-11.85 %

Quarters Operating Margin% % Change
Sep2025 22.77%
-10.21
Jun2025 25.36%
8.24
Mar2025 23.43%
-13.61
Dec2024 27.12%
4.99
Sep2024 25.83%
-6.68
Jun2024 27.68%
7.54
Mar2024 25.74%
-7.94
Dec2023 27.96% -

DR REDDYS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-5.62 %

Y-o-Y

-0.40 %

Quarters Profit After Tax % Change
Sep2025 ₹1,331 Cr
-5.62
Jun2025 ₹1,410 Cr
-10.85
Mar2025 ₹1,581 Cr
12.94
Dec2024 ₹1,400 Cr
4.81
Sep2024 ₹1,336 Cr
-3.66
Jun2024 ₹1,387 Cr
6.14
Mar2024 ₹1,306 Cr
-5.22
Dec2023 ₹1,378 Cr -
PAT Margins
Q-o-Q

-8.39 %

Y-o-Y

-9.33 %

Quarters PAT Margin(%) % Change
Sep2025 15.07 %
-8.39
Jun2025 16.45 %
-11.27
Mar2025 18.54 %
11.02
Dec2024 16.7 %
0.48
Sep2024 16.62 %
-7.77
Jun2024 18.02 %
-1.85
Mar2024 18.36 %
-3.57
Dec2023 19.04 % -

DR REDDYS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-5.01 %

Y-o-Y

-78.57 %

Quarters EPS % Change
Sep2025 ₹16.13
-5.01
Jun2025 ₹16.98
-11.10
Mar2025 ₹19.1
12.68
Dec2024 ₹16.95
-77.48
Sep2024 ₹75.28
350.78
Jun2024 ₹16.7
6.30
Mar2024 ₹15.71
-5.13
Dec2023 ₹16.56 -

You may also like the below Video Courses